Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan
Crossref DOI link: https://doi.org/10.1007/s00535-015-1052-5
Published Online: 2015-02-18
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sakaida, Isao
Nakajima, Koji
Okita, Kiwamu
Hori, Masatsugu
Izumi, Tohru
Sakurai, Masaya
Shibasaki, Yoshiyuki
Tachikawa, Sayaka
Tsubouchi, Hidetsugu
Oka, Hiromi
Kobayashi, Hiroyuki
License valid from 2015-02-18